New drug could reduce bulging eyes in thyroid disease patients
NCT ID NCT07113262
First seen Nov 17, 2025 · Last updated May 01, 2026 · Updated 24 times
Summary
This study tests a new medicine called IBI311 for people with inactive thyroid eye disease, a condition that causes the eyes to bulge. The goal is to see if the drug can reduce eye bulging by at least 2 millimeters. About 111 adults will take part, and the study lasts up to 64 weeks. Participants will receive either the drug or a placebo, and neither they nor their doctors will know which they get.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THYROID EYE DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First Affiliated Hospital of Medical University
RECRUITINGShenyang, Liaoning, 110801, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.